The controversy over the association between statins use and progression of age-related macular degeneration: a mini review | Zendy

Spyridon E. Chalkiadakis | Zendy

Open Access

The controversy over the association between statins use and progression of age-related macular degeneration: a mini review

Author(s) -

Spyridon E. Chalkiadakis

Publication year - 2010

Publication title -

clinical ophthalmology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.025

H-Index - 56

eISSN - 1177-5483

pISSN - 1177-5467

DOI - 10.2147/opth.s12869

Subject(s) - medicine , macular degeneration , ophthalmology , association (psychology) , optometry , psychotherapist , psychology

Age-related macular degeneration (AMD) is the leading cause of blindness in western societies. Statins comprise a class of pharmacological agents that reduce plasma cholesterol levels, and have been shown to prevent progression of atherosclerosis and reduce cardiovascular mortality. The relationship between these medications and AMD has been evaluated in several recent studies. Herein, we examine the current evidence for an association between statin use and risk of AMD.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research